CDL Nuclear · Anchor Notes
Anchor Note · CDL Nuclear

Call Extraction: CDL MedScout Discussion — Account Profiling Enhancement

Date
Thursday, October 30, 2025
Format
Gong · ~30 minutes
Participants
Phil Cranmer (CDL), Kathryn White (CS), Skylar Talley (MedScout Strategy), Andrew Janatka (MedScout Product Design)

Call Extraction: CDL MedScout Discussion — Account Profiling Enhancement

DDX ID: 0903 Date: 2025-10-30 Duration: ~30 minutes Participants: Phil Cranmer (CDL), Kathryn White (CS), Skylar Talley (MedScout Strategy), Andrew Janatka (MedScout Product Design). Call type: Product feedback and alignment. Account profiling improvements needed before broader sales team rollout. Triage: Moderate. Mostly platform improvement discussion, but Phil’s “four data points” and the org structure detail are fingerprint-relevant.

Distinct Insights

1. Phil’s four key data points — what CDL needs to assess any account

What: Phil: “I still got to know what they’re doing, which means I need to see those four data points to even know if I even want to have the meeting.” The four: cardiac PET, oncology PET, SPECT, and cardiac SPECT.

So what: CDL evaluates any healthcare facility through exactly four procedure volume indicators. Cardiac PET volume tells them if the facility is already doing what CDL sells (existing customer or competitor). Oncology PET volume tells them if the facility has a PET camera on-site that could be used for cardiac PET (CardioNavix play). SPECT volume tells them if there’s cardiac imaging demand (the conversion opportunity). Cardiac SPECT specifically narrows to the heart-related subset. These four numbers are sufficient for Phil to determine whether a meeting is worth having — before any deeper analysis of payer mix, referral patterns, or competitive landscape. It’s CDL’s qualification screen: if the four numbers don’t look right, nothing else matters.

Speaker credibility: Phil, defining the qualification criteria he uses daily. Very high. Scope: Universal across both motions. Any CDL rep assessing any account starts with these four. Motion: Both.

2. Lynette’s health system reps each cover one-third of the US

What: Phil: “Lynette heads up our health system sales team. She’s bouncing around the country with opportunities.” And: “Our geographies are huge. We’re talking a third of a country, a third of a country and a third of a country.”

So what: The health system team has enormous geographic territories — each of Lynette’s three direct reports covers roughly a third of the entire United States. This is structurally different from the private practice team, which has more localized BDMs doing geographic-cluster prospecting (Doug’s “fly into Charleston” approach). The massive territories mean health system reps can’t do the kind of dense geographic prospecting that works for private practice. They need to identify the highest-value targets nationally and travel to them selectively. This explains why Lynette needs instant account lookup (“type a name, hit enter, see the data”) rather than territory-based browsing — she’s not scanning a metro area, she’s researching specific hospitals across the country for planned visits.

Speaker credibility: Phil, describing his own org. Factual. Scope: Health system team structure. Motion: Hospital team.

3. “Dead end” problem reveals workflow disconnect

What: Phil: “It was sort of like a dead end. I’m like, well, this doesn’t help me, right?” When a rep searches for a specific account, they get basic facility info but can’t see the four procedure volumes that determine whether a meeting is worthwhile.

So what: CDL’s reps get account names from multiple sources — referrals, conferences, inbound leads, competitor intelligence. Their first action is to qualify: does this facility’s procedure volume profile justify a meeting? If the platform shows the account name but not the volumes, the rep hits a dead end and has to either search elsewhere (Excel file, Acuity, Google) or just schedule the meeting blind. Phil estimates the upcoming platform update will solve this for ~75% of typical use cases. The insight for the fingerprint: CDL’s data tool needs to support both structured targeting (pre-built strategies for territory scanning) AND ad-hoc qualification (instant lookup for any account from any source). These are different workflows with different UX requirements, and the platform needs to serve both.

Speaker credibility: Phil, describing a real daily friction. High. Scope: Both motions — both PP and HS reps encounter this. Motion: Both.

Transcription Notes

  • Andrew Janatka — MedScout Product Design Lead. First appearance in extraction notes.
  • This call included Skylar Talley, MedScout’s strategy lead. Context: Skylar shapes product direction and would be the escalation target Phil references in 1306 (Feb 2026).
  • “Top 500” limitation mentioned — the platform limits analysis to top 500 opportunities per territory for performance. CDL’s use case requires broader coverage.